Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Domchek

Showing results (201-210 of 361) with videos related to

Pageof 37
Sort By:
Cancer Medicine|June 8, 2021
Randomized study of remote telehealth genetic services versus usual care in oncology practices without genetic counselorsCara N Cacioppo, Brian L Egleston, Dominique Fetzer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 21, 2026
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in Women with Pathogenic BRCA1/2 VariantsGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 14, 2021
Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancerJada G Hamilton, Heather Symecko, Kelsey Spielman, et al.
Journal of the American Heart Association|January 22, 2020
Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac DysfunctionBiniyam G Demissei, Rebecca A Hubbard, Liyong Zhang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 13, 2012
Genetic susceptibility to type 2 diabetes and breast cancer risk in women of European and African ancestryNingqi Hou, Yonglan Zheng, Eric R Gamazon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2008
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective studyNoah D Kauff, Susan M Domchek, Tara M Friebel, et al.
Breast Cancer Research and Treatment|February 25, 2010
Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriersSusan M Domchek, Tara M Friebel, Judy E Garber, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
High-throughput mapping of 6,888 <i>RAD51D</i> variants identifies distinct biochemical functions needed for homologous recombination and olaparib responseKristie E Darrah, Shelby L Hemker, Yashpal Rawal, et al.
JCO Precision Oncology|July 9, 2025
LODESTAR: A Single-Arm Phase II Study of Rucaparib in Solid Tumors With Pathogenic Germline or Somatic Variants in Homologous Recombination Repair GenesSriram Anbil, Nicholas J Seewald, E Gabriela Chiorean, et al.
Nature Communications|August 24, 2017
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriersKara N Maxwell, Bradley Wubbenhorst, Brandon M Wenz, et al.
Pageof 37

Showing results (201-210 of 361) with videos related to

Sort By:
Pageof 37
Cancer Medicine|June 8, 2021
Randomized study of remote telehealth genetic services versus usual care in oncology practices without genetic counselorsCara N Cacioppo, Brian L Egleston, Dominique Fetzer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 21, 2026
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in Women with Pathogenic BRCA1/2 VariantsGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 14, 2021
Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancerJada G Hamilton, Heather Symecko, Kelsey Spielman, et al.
Journal of the American Heart Association|January 22, 2020
Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac DysfunctionBiniyam G Demissei, Rebecca A Hubbard, Liyong Zhang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 13, 2012
Genetic susceptibility to type 2 diabetes and breast cancer risk in women of European and African ancestryNingqi Hou, Yonglan Zheng, Eric R Gamazon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2008
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective studyNoah D Kauff, Susan M Domchek, Tara M Friebel, et al.
Breast Cancer Research and Treatment|February 25, 2010
Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriersSusan M Domchek, Tara M Friebel, Judy E Garber, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
High-throughput mapping of 6,888 <i>RAD51D</i> variants identifies distinct biochemical functions needed for homologous recombination and olaparib responseKristie E Darrah, Shelby L Hemker, Yashpal Rawal, et al.
JCO Precision Oncology|July 9, 2025
LODESTAR: A Single-Arm Phase II Study of Rucaparib in Solid Tumors With Pathogenic Germline or Somatic Variants in Homologous Recombination Repair GenesSriram Anbil, Nicholas J Seewald, E Gabriela Chiorean, et al.
Nature Communications|August 24, 2017
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriersKara N Maxwell, Bradley Wubbenhorst, Brandon M Wenz, et al.
Pageof 37